Skip to main content

Sleep Disturbance

1
Pipeline Programs
6
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
1
Sleep restrictionPhase 11 trial
Active Trials
NCT01642719Completed200Est. Dec 2018
Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
Sleep Well!N/A1 trial
Targeted Approaches for Promoting Adolescent SleepN/A1 trial
Active Trials
NCT04473222Completed103Est. Jul 2023
NCT04163003Completed82Est. Aug 2022
Holobiome
HolobiomeMA - Boston
1 program
Active Gut Feeling Product 1N/A1 trial
Active Trials
NCT07752823Not Yet Recruiting1,000Est. Aug 2027
Harmony Biosciences
Harmony BiosciencesPLYMOUTH MEETING, PA
1 program
EMF ProtectionN/A1 trial
Active Trials
NCT07746011Completed24Est. Nov 2025
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
TranS-CN/A1 trial
Active Trials
NCT06963463Recruiting90Est. Jul 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Angeles TherapeuticsSleep restriction
HolobiomeActive Gut Feeling Product 1
Harmony BiosciencesEMF Protection
Oregon TherapeuticsTranS-C
Human BioSciencesSleep Well!
Human BioSciencesTargeted Approaches for Promoting Adolescent Sleep

Clinical Trials (6)

Total enrollment: 1,499 patients across 6 trials

NCT01642719Angeles TherapeuticsSleep restriction

Chronic Moderate Sleep Restriction in Older Adults

Start: Jul 2012Est. completion: Dec 2018200 patients
Phase 1Completed
NCT07752823HolobiomeActive Gut Feeling Product 1

GUT-FEELINGS: Using Citizen Science for Large-Scale Prebiotic Clinical Trials for Mental Health in Adults

Start: Aug 2026Est. completion: Aug 20271,000 patients
N/ANot Yet Recruiting
NCT07746011Harmony BiosciencesEMF Protection

A Clinical Trial to Evaluate the Effects of EMF Protection Devices on Sleep and Energy Levels

Start: Aug 2025Est. completion: Nov 202524 patients
N/ACompleted
NCT06963463Oregon TherapeuticsTranS-C

Transdiagnostic Sleep and Circadian Intervention + Bright Light in Adolescents With Elevated Depression (TranS-C+BL)

Start: May 2025Est. completion: Jul 202790 patients
N/ARecruiting
NCT04473222Human BioSciencesSleep Well!

Behavioral Sleep Intervention in Urban Primary Care: Aim 3

Start: Oct 2020Est. completion: Jul 2023103 patients
N/ACompleted
NCT04163003Human BioSciencesTargeted Approaches for Promoting Adolescent Sleep

Targeted Intervention for Insufficient Sleep Among Typically-Developing Adolescents

Start: Oct 2019Est. completion: Aug 202282 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 1,499 patients
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.